Related Experiment Video
Updated: Apr 25, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
[SAR of benzoyl sulfathiazole derivatives as PTP1B inhibitors]
Abstract:
Protein tyrosine phosphatase (PTP) 1B is a potential target for the treatment of diabetes and obesity. We have previously identified the benzoyl sulfathiazole derivative II as a non-competitive PTP1B inhibitor with in vivo insulin sensitizing effects. Preliminary SAR study on this compound series has been carried out herein, and thirteen new compounds have been designed and synthesized. Among them, compound 10 exhibited potent inhibition against human recombinant PTP1B with the IC50 value of 3.97 micromol x L(-1), and is comparable to that of compound II.
More Related Videos
Related Concept Videos
Electrophilic Aromatic Substitution: Sulfonation of Benzene
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Preparation and Reactions of Sulfides
Structure and Nomenclature of Thiols and Sulfides
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Directing and Steric Effects in Disubstituted Benzene Derivatives

